Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997

Journal of Infectious Diseases

Volumn 183, Issue 1, 2001, Pages 16-22

  Shay, David K ^a   Holman, Robert C ^b   Roosevelt, Genie E ^c   Clarke, Matthew J ^b   Anderson, Larry J ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRONCHIOLITIS; CAUSE OF DEATH; CHILD; CONGENITAL HEART DISEASE; FEMALE; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT DISEASE; UNITED STATES;

BRONCHIOLITIS; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SEASONS; UNITED STATES;

EID: 0035168864     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/317655     Document Type: Article

References (54)

1. The global burden of disease in 1990: Final results and their sensitivity to alternative epidemiological perspectives, discount rates, age-weights and disability weights
2. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries
3. Bronchiolitis-associated hospitalizations among US children, 1980-1996
4. Epidemiology of respiratory syncytial virus infections in Washington DC. II
5. Risk of primary infection and reinfection with respiratory syncytial virus
6. Respiratory syncytial virus
7. Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children
8. The prospects for immunizing against respiratory syncytial virus
9. Respiratory syncytial virus infection in infants with congenital heart disease
10. Improved outcome of respiratory syncytial infection in a high-risk hospitalized population of Canadian children
11. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: A recent experience
12. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
13. Questions about palivizumab (Synagis): In reply
14. Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants
15. Analytical potential for multiple cause-of-death data
16. The 1989 revision of the US standard certificates and reports
17. History and organization of the vital statistics system
18. Respiratory syncytial virus infection in children with congenital heart disease: A review
19. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia
20. Rehospitalization for respiratory syncytial virus among premature infants
21. Poisson regression anal ysis
22. Epidemiology of respiratory syncytial virus infection in Washington, DC. I. Importance of the virus different respiratory tract disease syndromes and temporal distribution of infection
23. A comparison of influenza and respiratory syncytial virus infections among infants admitted to hospital with acute respiratory infections
24. Respiratory syncytial virus infection: Admissions to hospital in industrial, urban and, rural areas
25. Respiratory syncytial virus infections in Oslo, 1972-1978. II. Clinical and laboratory studies
26. Respiratory syncytial virus: A report of a 5-year study at a children's hospital
27. Epidemiology of respiratory syncytial virus infection in Washington, DC. III. Composite analysis of eleven consecutive yearly epidemics
28. Respiratory syncytial virus infection in north-east England
29. Hospitalization of Jewish and Bedouin infants in southern Israel for bronchiolitis caused by respiratory syncytial virus
30. Respiratory syncytial virus infection in lower respiratory tract and asthma attack in hospitalized children in North Hokkaido, Japan
31. Viral etiology and epidemiology of acute lower respiratory tract infections in Korean children
32. Respiratory syncytial virus infection: Admissions to hospital in industrial, urban, and rural areas
33. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group and maternal antibody level
34. Respiratory syncytial virus pneumonia among the elderly: An assessment of disease burden
35. Sample selection and the natural history of disease. Studies of febrile seizures
36. Referral bias in multiple sclerosis research
37. Referral bias in diabetes research
38. Respiratory viruses and sudden infant death
39. Infant mortality statistics do not adequately reflect the impact of short gestation
40. Death certificate reports of cardiovascular disorders in children: Comparison with diagnoses in a pediatric cardiology registry
41. Respiratory syncytial virus infection in infants and young children
42. Dexamethasone in bronchiolitis: A randomized controlled trial
43. Prednisolone treatment of respiratory syncytial virus infection: A randomized controlled trial of 147 infants
44. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection
45. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial
46. The use of albuterol in hospitalized infants with bronchiolitis
47. 2-agonists in bronchiolitis: A reappraisal and meta-analysis
48. Pediatric Investigators Collaborative Network in Infections in Canada (PICNIC) study of admission and management variation m patients hospitalized with respiratory syncytial viral lower respirator tract infection